NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
    India

    Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech

    Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
    Written by Abhishek Hari
    Jun 19, 2022, 04:12 pm 3 min read
    Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
    The data analysis for the world's first nasal COVID-19 vaccine is currently underway and clinical trials have concluded.

    The phase 3 clinical trials of Bharat Biotech's COVID-19 nasal vaccine have been completed, according to Dr. Krishna Ella, the company's Chairman and Managing Director. The company will submit its data to the Drugs Controller General of India (DCGI) next month. "If everything's okay, we'll get permission to launch, and it will be the world's first clinically proven nasal COVID-19 vaccine," he reportedly stated.

    Why does this story matter?

    • Experts say nasal COVID-19 vaccines could be a game-changer in the global fight against the COVID-19 pandemic.
    • They are reportedly easier to store, can be transported without refrigeration, and also remove injury risks that are associated with needle-based vaccines.
    • Dr. Soumya Swaminathan, the chief scientist at the World Health Organization (WHO), had earlier described such treatments as a "second generation" of coronavirus vaccines.

    Statement of Dr. Ella over the development

    In a recent interview with ANI, Dr. Ella stated, "We just completed a clinical trial. Data analysis is going on. Next month, we will submit the data to the regulatory agency." Dr. Ella was speaking at Viva Technology 2022 in Paris, where India was named country of the year. Notably, intranasal vaccines reportedly have the potential to prevent new COVID-19 variants like Omicron.

    DCGI granted Bharat Biotech permission to perform trials in January

    India's drug controller granted Bharat Biotech permission to perform standalone phase 3 trials of its COVID-19 nasal vaccine in January 2022. In addition, the DCGI's Subject Expert Committee (SEC) gave Bharat Biotech's "in-principle" approval for the "phase 3 booster dose study" for its first-of-its-kind intranasal COVID-19 vaccine and requested that it to submit protocols for approval a few weeks ago.

    How does an intra-nasal vaccine work?

    According to Bharat Biotech's website, "An intra-nasal vaccine stimulates a broad immune response neutralizing IgG, mucosal IgA, and T cell responses and creates an immune response at the site of infection (in the nasal mucosa) essential for blocking both infection and transmission of COVID-19." In India, Bharat Biotech is the second organization to apply for the phase 3 test of the third dose.

    Booster is miracle dose for every vaccination: Dr. Ella

    While highlighting the importance of the COVID-19 booster dose, Dr. Ella stated, "I always say...booster dose is a miracle dose for every vaccination. Even in children, two doses don't give much immunity, but the third dose gives an amazing response... The same thing is for adults also." "The third dose is very important for adults," he added, stating that COVID-19 can't be eradicated.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Paris
    World Health Organization
    Ministry of Health and Family Welfare
    Drugs Controller General of India

    Latest

    Audi Q3 Sportback bookings open: Check alternative SUVs before ordering Audi
    'Salaam Venky': Kajol's emotionally-charged film gets an OTT release date!  ZEE5
    #NewsBytesExplainer: Is Quora's Poe a ChatGPT rival or something else Quora
    Adani-Hindenburg row: Opposition stalls parliament proceedings, seeks PM Modi's response Parliament

    Paris

    Go First fined Rs 10 lakh for leaving passengers behind Directorate General of Civil Aviation
    Viktor & Rolf turned fashion upside-down at Paris Fashion Week Fashion Design
    Weird highlights from Schiaparelli's 2023 Paris Fashion Week Show Fashion Tips
    Air India receives DGCA notice for not reporting unruly passengers Directorate General of Civil Aviation

    World Health Organization

    Cough syrup deaths: WHO urges countries to take immediate action Gambia
    Woman dies after quack conducts illegal abortion in Bihar's Hajipur  Bihar
    Omicron subvariant XBB.1.5: What do we know so far COVID-19
    WHO recommends against using India-made cough syrups after Uzbekistan deaths Uzbekistan

    Ministry of Health and Family Welfare

    Marion Biotech, linked to Uzbekistan kids' death, halts production   Uttar Pradesh
    Uzbekistan links death of 18 kids to Noida-made cough syrup Noida
    COVID-19 test mandatory for arrivals from China, 4 other countries COVID-19
    Mumbai's measles death tally reaches 12, Centre issues advisory Measles

    Drugs Controller General of India

    Serum Institute seeks DCGI's approval for Covovax as booster dose Serum Institute of India
    Lumpy skin disease kills 67,000 cattle across India: Details here Narendra Modi
    DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years COVID-19 Vaccine
    COVAXIN likely to get approval for children above 2yrs: Report COVID-19

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023